A recent study showed that rates of antiretroviral therapy in enrollees living with HIV increased over the years, but women ...

As the new cases and related deaths fall in sub-Saharan Africa, the virus is rearing its head elsewhere. What's the cause?

Merck's experimental two-drug combination met the main goal of significantly suppressing replication of the HIV-1 virus in ...

HIV stigma and discrimination continue to harm the lives of people living with HIV, and hinder efforts to stem the epidemic ...

Speaking at the 16th International Aids Conference in 2006, the then UNAids executive director, Peter Piot, remarked: "Since ...

U.S. drugmaker Merck said on Thursday its experimental combination treatment for some adults with HIV-1 infection met the ...

The human immune deficiency virus (HIV) first entered public consciousness in the early 1980s, after cases of unfamiliar and ...

This issue highlights a broader concern regarding medication coverage and affordable health care. It underscores the critical ...

The prevalence of HPV81 in mother-child pairs with HIV in Nigeria could have implications on vaccination against human ...

Introduced in Malawi in 2015, the HeForShe initiative engages men and boys as allies in dismantling patriarchal norms and ...

As we mark the holidays, here are a few of the many heroes who are working to build a stronger global health future by ...

HIV encephalopathy, a severe brain complication of HIV/AIDS, affects memory and cognition. Expert stresses early intervention ...